Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway
Jing Lv(Wuhan City Chinese Medicine Hospital), Yunfu Wang(Hubei University of Medicine), Qiang Sun(Hubei University of Medicine), Yiran Lan(Hubei University of Medicine), Jiang Yuan(Hubei University of Medicine), Peihan Wang(Hubei University of Medicine), Guoda Ding(Taihe Hospital), Zihan Wang(China University of Geosciences (Beijing)), Zhifeng Zhang(Hubei University of Medicine), Huan Yin(Dongfang Electric Corporation (China)), Huajie Wang(Hubei University of Medicine), Jing Zhu(Southern University of Science and Technology), Tongyu Liu(Hubei University of Medicine), Chenxi Zhou(University of Cambridge)
Cited by 27
Related Papers
Recent Advances in Nanotheranostics for Treat‐to‐Target of Rheumatoid Arthritis
|Advanced Healthcare Materials|2020|65
<p>Dexmedetomidine attenuates the neurotoxicity of propofol toward primary hippocampal neurons in vitro via Erk1/2/CREB/BDNF signaling pathways</p>
|Drug Design Development and Therapy|2019|64
Dexmedetomidine attenuates propofol-induce neuroapoptosis partly via the activation of the PI3k/Akt/GSK3β pathway in the hippocampus of neonatal rats
|Environmental Toxicology and Pharmacology|2017|59
Abnormalities in resting-state EEG microstates are a vulnerability marker of migraine
|The Journal of Headache and Pain|2022|59
RIPC provides neuroprotection against ischemic stroke by suppressing apoptosis via the mitochondrial pathway
|Scientific Reports|2020|58